Found 3 results
Author Title Type [ Year(Asc)]
Filters: Author is Buggage, Ronald R  [Clear All Filters]
2007
R. R. Buggage, Levy-Clarke, G., Sen, H. N., Ursea, R., Srivastava, S. K., Suhler, E. B., Altemare, C., Velez, G., Ragheb, J., Chan, C. - C., Nussenblatt, R. B., Bamji, A. T., Sran, P., Waldmann, T., and Thompson, D. J. S., “A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.”, Ocul Immunol Inflamm, vol. 15, no. 2, pp. 63-70, 2007.
2005
R. B. Nussenblatt, Peterson, J. S., C Foster, S., Rao, N. A., See, R. F., Letko, E., and Buggage, R. R., “Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.”, Ophthalmology, vol. 112, no. 5, pp. 764-70, 2005.
2003
R. B. Nussenblatt, Thompson, D. J. S., Li, Z., Chan, C. Chao, Peterson, J. S., Robinson, R. R., Shames, R. S., Nagarajan, S., Tang, M. Tao, Mailman, M., Velez, G., Roy, C., Levy-Clarke, G. A., Suhler, E. B., Djalilian, A., Sen, H. Nida, Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Mellow, S., Sran, P., Waldmann, T. A., and Buggage, R. R., “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration.”, J Autoimmun, vol. 21, no. 3, pp. 283-93, 2003.